+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Caprion Biosciences - logo

Caprion Pharmaceuticals is a drug discovery and development company engaged in the discovery and development of proteomics pharmaceutical products in oncology and infectious disease. The company's clinical-stage programs include Shigamabs, a product for the treatment of shigatoxin-producing bacterial infections, and CAP-232, a therapy with potential efficacy in multiple oncology indications. Caprion Pharmaceuticals, Inc. was founded in 1998 and is based in Montreal, Canada.

From
From
From
From
From
From
From
Global Biotech Partnering Terms and Agreements 2016-2020 - Product Thumbnail Image

Global Biotech Partnering Terms and Agreements 2016-2020

  • Report
  • September 2020
  • 2900 Pages
From
Global Markets for Protein Labeling - Product Thumbnail Image

Global Markets for Protein Labeling

  • Report
  • February 2017
  • 176 Pages
From
Canada Infectious Diagnostics Market Outlook to 2024 - Product Thumbnail Image

Canada Infectious Diagnostics Market Outlook to 2024

  • Report
  • November 2017
  • 154 Pages
From
Americas COVID-19 Progress Daily - Product Thumbnail Image

Americas COVID-19 Progress Daily

  • Report
  • September 2020
  • 6 Pages
From
Proteome Profiling Services Market, 2020-2030 - Product Thumbnail Image

Proteome Profiling Services Market, 2020-2030

  • Report
  • June 2020
  • 295 Pages
From
Loading Indicator
adroll